We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+8.83%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$76.1B
AUM Growth
+$4.53B
Cap. Flow
-$133M
Cap. Flow %
-0.17%
Top 10 Hldgs %
16.55%
Holding
798
New
67
Increased
286
Reduced
299
Closed
53

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$550M
2
GS icon
Goldman Sachs
GS
+$448M
3
COP icon
ConocoPhillips
COP
+$390M
4
BWA icon
BorgWarner
BWA
+$373M
5
MPC icon
Marathon Petroleum
MPC
+$365M

Top Sells

Rank Stock Value
1
MCK icon
McKesson
MCK
+$545M
2
OXY icon
Occidental Petroleum
OXY
+$491M
3
VZ icon
Verizon
VZ
+$433M
4
RTN
Raytheon Company
RTN
+$266M
5
AON icon
Aon
AON
+$238M

Sector Composition

Rank Sector Weight
1 Financials 27.05%
2 Healthcare 13.47%
3 Technology 12.73%
4 Energy 10.48%
5 Industrials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSTB
651
DELISTED
Park Sterling Corp.
PSTB
$2.41M ﹤0.01%
223,034
+5,954
+3% +$55.5K
KERX
652
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$2.4M ﹤0.01%
409,051
JOBS
653
DELISTED
51job Inc
JOBS
$2.36M ﹤0.01%
69,720
PWR icon
654
Quanta Services
PWR
$93.9B
$2.34M ﹤0.01%
67,266
-45,435
-40% -$1.43M
EXC icon
655
Exelon
EXC
$48.6B
$2.34M ﹤0.01%
92,358
+48,871
+112% +$1.16M
AVNT icon
656
Avient
AVNT
$3.45B
$2.32M ﹤0.01%
72,281
+1,956
+3% +$62.8K
ATH
657
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$2.29M ﹤0.01%
+47,696
New +$2.21M
CCRN
658
DELISTED
Cross Country Healthcare
CCRN
$2.29M ﹤0.01%
146,600
-84,570
-37% -$1.16M
BH icon
659
Biglari Holdings Class B
BH
$1.2B
$2.22M ﹤0.01%
7,032
CNXN icon
660
PC Connection
CNXN
$2.05B
$2.21M ﹤0.01%
78,846
+1,894
+2% +$50.2K
CDI
661
DELISTED
CDI Corp.
CDI
$2.21M ﹤0.01%
298,739
WYNN icon
662
Wynn Resorts
WYNN
$10.1B
$2.18M ﹤0.01%
25,176
+7,077
+39% +$662K
AIN icon
663
Albany International
AIN
$2.14B
$2.16M ﹤0.01%
46,719
CVEO icon
664
Civeo
CVEO
$379M
$2.15M ﹤0.01%
81,551
+2,164
+3% +$44K
ACBI
665
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$2.15M ﹤0.01%
112,936
-53,940
-32% -$862K
SB icon
666
Safe Bulkers
SB
$781M
$2.13M ﹤0.01%
+1,855,566
New +$2.54M
HALL
667
DELISTED
Hallmark Financial Services, Inc.
HALL
$2.13M ﹤0.01%
18,290
-4,586
-20% -$498K
FNHC
668
DELISTED
FedNat Holding Company Common Stock
FNHC
$2.02M ﹤0.01%
+108,230
New +$1.92M
TPR icon
669
Tapestry
TPR
$28.8B
$2.02M ﹤0.01%
57,600
-173,000
-75% -$6.31M
EBF icon
670
Ennis
EBF
$546M
$1.96M ﹤0.01%
112,925
+2,943
+3% +$47.9K
CERN
671
DELISTED
Cerner Corp
CERN
$1.93M ﹤0.01%
40,800
EMBJ
672
Embraer S.A. ADS
EMBJ
$11.6B
$1.93M ﹤0.01%
100,000
MGNI icon
673
Magnite
MGNI
$2.65B
$1.92M ﹤0.01%
+258,521
New +$2.01M
MIND icon
674
MIND Technology
MIND
$50.4M
$1.86M ﹤0.01%
44,873
HCKT icon
675
Hackett Group
HCKT
$245M
$1.86M ﹤0.01%
105,400
-105,830
-50% -$1.79M

Similar funds

Boston Partners's Q4 2016 Portfolio in Review

As of Q4 2016, Boston Partners held 798 positions worth $76.1B, up 6.3% from $71.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Partners's Q4 2016 filing shows 67 new, 286 increased, 299 reduced and 53 closed positions. Its largest new stake was BorgWarner: 11,568,722 shares worth $402M. The largest sale was McKesson, an estimated $545M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.

  • Boston Partners's largest Q4 2016 buy was BorgWarner: 11,568,722 shares worth $402M.
  • Boston Partners added most to Pfizer in Q4 2016, an estimated $550M increase.
  • Boston Partners's biggest Q4 2016 reduction was McKesson, cutting an estimated $545M.
  • Boston Partners fully exited Valspar in Q4 2016, selling an estimated $177M.
  • Boston Partners's ten largest holdings make up 17% of its $76.1B portfolio in Q4 2016.
  • Boston Partners opened 67 new positions and closed 53 in Q4 2016.
  • Boston Partners's portfolio value rose 6.3% quarter-over-quarter to $76.1B.

Based on Boston Partners's 13F filing for Q4 2016, filed 6 Feb 2017.